To address this possibility, we evaluated the effect of exogenous TGF-β1 on an experimentally evolved non-small cell lung cancer cell line that we previously developed and used to investigate the biology of CTC clusters. The gene discussed is TGFB1; the disease is non-small cell lung carcinoma.